Skip to content
Disclosery

B Group, Inc.

Follow

13F filer, CIK 2043476, DALLAS, TX

B Group, Inc. reported $213,008,589 across 19 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 79.23% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-001657

Period
2026-06-30
Reported value
$213M
Holdings
19
Top 10 weight
79.23%
New
2
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FTHnew+610,169$15.3M
NRXPadded+1,091,767$4.47M
AURAadded+166,667$1.18M
GPCRadded+12,500$671K
FHTXadded+98,000$478K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SYREreduced-30,000-$2.66M
APGEexited-7,500-$631K
SLNOexited-7,500-$251K
REPLexited-26,000-$199K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001420506-26-001657, largest first. % of portfolio is the value over $176,188,589, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 2,287,542 shares; 2025Q1: 2,317,542 shares; 2025Q2: 2,317,542 shares; 2025Q3: 2,412,542 shares; 2025Q4: 2,457,542 shares; 2026Q1: 3,207,542 shares; 2026Q2: 3,262,542 shares 3,262,542$27.3M15.5%+55,000Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,500,000 shares; 2026Q1: 11,414,285 shares; 2026Q2: 11,414,285 shares 11,414,285$23.9M13.54%0Timeline
NRXPNRX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,000,000 shares; 2026Q2: 4,091,767 shares 4,091,767$16.7M9.5%+1,091,767Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 610,169 shares 610,169$15.3M8.66%newTimeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 965,556 shares; 2025Q1: 1,255,556 shares; 2025Q2: 1,800,556 shares; 2025Q3: 1,800,556 shares; 2025Q4: 1,800,556 shares; 2026Q1: 1,800,556 shares; 2026Q2: 1,800,556 shares 1,800,556$12.3M6.96%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 19,000 shares; 2025Q2: 35,000 shares; 2025Q3: 31,500 shares; 2025Q4: 33,237 shares; 2026Q1: 33,237 shares; 2026Q2: 33,237 shares 33,237$11.1M6.32%0Timeline
CLLSCELLECTIS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 3,081,501 shares; 2025Q1: 3,256,501 shares; 2025Q2: 3,256,501 shares; 2025Q3: 3,281,501 shares; 2025Q4: 3,281,501 shares; 2026Q1: 3,281,501 shares; 2026Q2: 3,281,501 shares 3,281,501$9.84M5.59%0Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 400,000 shares; 2025Q1: 400,000 shares; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: 400,000 shares; 2026Q1: 450,646 shares; 2026Q2: 450,646 shares 450,646$8.56M4.86%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares; 2026Q1: 127,500 shares; 2026Q2: 140,000 shares 140,000$7.51M4.26%+12,500Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 20,000 shares; 2025Q1: 58,215 shares; 2025Q2: 75,000 shares; 2025Q3: 75,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares 75,000$7.14M4.05%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 992,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares; 2026Q2: 1,500,000 shares 1,500,000$6.24M3.54%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 70,000 shares; 2025Q2: 80,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 70,000 shares 70,000$6.21M3.53%-30,000Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 472,576 shares; 2025Q1: 472,576 shares; 2025Q2: 572,576 shares; 2025Q3: 572,576 shares; 2025Q4: 572,576 shares; 2026Q1: 597,576 shares; 2026Q2: 764,243 shares 764,243$5.43M3.08%+166,667Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 50,651 shares; 2025Q1: 200,000 shares; 2025Q2: 189,350 shares; 2025Q3: 175,706 shares; 2025Q4: 175,706 shares; 2026Q1: 175,706 shares; 2026Q2: 175,706 shares 175,706$4.83M2.74%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 67,500 shares; 2026Q2: 67,500 shares 67,500$4.74M2.69%0Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 7,596 shares; 2025Q1: 47,500 shares; 2025Q2: 110,000 shares; 2025Q3: 135,000 shares; 2025Q4: 135,000 shares; 2026Q1: 135,000 shares; 2026Q2: 135,000 shares 135,000$4.51M2.56%0Timeline
SGHTSIGHT SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: 629,370 shares; 2025Q1: 833,600 shares; 2025Q2: 930,000 shares; 2025Q3: 930,000 shares; 2025Q4: 920,000 shares; 2026Q1: 970,000 shares; 2026Q2: 970,000 shares 970,000$3.66M2.08%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 102,000 shares; 2026Q2: 200,000 shares 200,000$976K0.55%+98,000Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
INVESCO QQQ TRINVESCO QQQ TR PUTput50,000$36.8Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC7,500$631Kshares
SLNOSOLENO THERAPEUTICS INC7,500$251Kshares
REPLREPLIMUNE GROUP INC26,000$199Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-001657 base2026-08-14acceptance time not in the bulk data set